Showing 241 - 260 results of 105,415 for search '(( 5 ((((nm decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a de decrease ))', query time: 1.53s Refine Results
  1. 241

    Predicted targets of miR-337-3p decrease in mRNA expression on over-expression of miR-337-3p. by Liqin Du (158175)

    Published 2012
    “…<p>(A) Expression levels of miR-337-3p after 72 h transfection of NCI-H1155 cells with 50 nM miR-337-3p mimic as measured by qRT-PCR. …”
  2. 242

    Binding sensogram (a) showing decrease in frequency of crystal immobilised with 1.5 M short aptamer exposed to different concentrations of heparanase. by Suzanne C. Simmons (319222)

    Published 2013
    “…<p>Higher concentrations of heparanase exhibited a greater decrease in frequency. Binding and regeneration sensogram (b) for addition of 800 nM heparanase to a quartz crystal immobilised with 1.5 M short aptamer. …”
  3. 243
  4. 244
  5. 245

    Decreased branching, partial right isomerization and epithelial proximalization in CKO lungs. by Stijn P. De Langhe (38981)

    Published 2008
    “…<p>(a–d) β-gal staining of <i>Dermo1<sup>Cre/+</sup>/Rosa26R</i> WT lungs at E11.5 and E13.5 reports Cre recombination activity in the mesenchyme of the embryonic lung. …”
  6. 246
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256
  17. 257

    Supplementary Material for: 3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma by Stankevicius D. (4130146)

    Published 2012
    “…We also showed that MDMA decreased expression of both Th2-like cytokines (IL-4, IL-5 and IL-10) and adhesion molecules (L-selectin). …”
  18. 258
  19. 259
  20. 260

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”